Recursos de NCI

NCI CANCERLIT^® Search: Myeloproliferative Disorders - October 2001 Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. Screening of Bcr-Abl transcripts in Philadelphia negative essential ...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - September 2001 Table of ContentsMyeloid metaplasia of the breast.The pathogenesis of chronic myeloproliferative diseases.Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid ...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - April 2002 Leukemoid reaction associated with transitional cell carcinoma. Is the gain of 9p involved in the pathogenesis of polycythemia vera? A purpose of a case. Melphalan treatment in patients with myelofibrosis with myeloid metaplasia....
NCI CANCERLIT^® Search: Myeloproliferative Disorders - August 2002 Osteogenic differentiation of mesenchymal stem cells derived from bone marrow of patients with myeloproliferative disorders. Unusually prolonged survival of a case of acute megakaryoblastic leukemia secondary to long-standing polycythemia...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - February 2002 Disturbance of cellular iron uptake and utilisation by aluminium. Rapidly relapsing squamous cell carcinoma of the renal pelvis associated with paraneoplastic syndromes of leukocytosis, thrombocytosis and Comparative effects of interferon and...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - January 2002 Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms. Unusual paranasal sinus tumors in two patients with common nasal complaints. Myeloproliferative disorders....
NCI CANCERLIT^® Search: Myeloproliferative Disorders - July 2002 Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - June 2002 Mesenteric inflammatory pseudotumor: unusual presentation with leukemoid reaction and massive calcified mass. Poor prognosis associated with thrombocytosis in patients with gastric cancer. High reliability and sensitivity of the BCR/ABL1...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - March 2002 Early elevation of serum thrombopoietin levels and subsequent thrombocytosis in healthy preterm infants. [Polycythemia vera] Skin lesion caused by hydroxyurea. [Association between hepatocellular carcinoma and polycythemia vera] Transforming...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - May 2002 Erythroleukemia: a comparison between the previous FAB approach and the WHO classification. On the diagnosis of polycythaemia vera as assessed in the health and medical care in the Vastra Gotaland region, Sweden. Allogeneic blood cell...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - October 2002 Acute promyelocytic leukemia with marrow fibrosis at initial presentation: possible involvement of transforming growth Bone marrow reticulin fibrosis at diagnosis in promyelocytic leukaemia treated with all-trans retinoic acid has no...
NCI CANCERLIT^® Search: Myeloproliferative Disorders - September 2002 A molecular star in the wars against cancer. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid...
NCI/PDQ^® Health professionals: Chronic Myeloproliferative Disorders Treatment (PDQ®) TABLE OF CONTENTS General Information About Chronic Myeloproliferative DisordersChronic Myelogenous LeukemiaPolycythemia VeraDisease OverviewTreatment OverviewCurrent Clinical TrialsPrimary MyelofibrosisDisease OverviewTreatment OverviewCurrent...
NCI/PDQ^® Health professionals: Myelodysplastic Syndromes Treatment (PDQ®) TABLE OF CONTENTS General Information About Myelodysplastic SyndromesIncidence and MortalityPrognosisPathologyClinical FeaturesRisk FactorsRelated SummaryPathologic and Prognostic Systems for Myelodysplastic SyndromesPathologic SystemsRefractory...
NCI/PDQ^® Health professionals: Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®) TABLE OF CONTENTS General Information About Myelodysplastic/ Myeloproliferative NeoplasmsChronic Myelomonocytic LeukemiaDisease Overview Treatment Overview for Myelodysplastic/ Myeloproliferative NeoplasmsCurrent Clinical TrialsJuvenile...
NCI/PDQ^® Pacientes: Enfermedades mielodisplásicas y mieloproliferativas TABLE OF CONTENTS Descripción¿Qué son las enfermedades mielodisplásicas y mieloproliferativas?Explicación de las estadiosEstadios de las enfermedades mielodisplásicas y mieloproliferativasAspectos generales de las...
NCI/PDQ^® Pacientes: Síndromes mielodisplásicos TABLE OF CONTENTS Descripción¿Qué son los síndromes mielodisplásicos?Explicación de las estadiosEstadios de los síndromes mielodisplásicosSíndromes mielodisplásicos de novoSíndromes...
NCI/PDQ^® Pacientes: Trastornos mieloproliferativos crónicos TABLE OF CONTENTS Descripción¿Qué son trastornos mieloproliferativos?Explicación de los estadiosEstadios de trastornos mieloproliferativosAspectos generales de las opciones de tratamientoTratamiento de los trastornos...
NCI/PDQ^® Patients: Chronic Myeloproliferative Disorders Treatment (PDQ®) TABLE OF CONTENTS General Information About Chronic Myeloproliferative DisordersChronic Myelogenous LeukemiaPolycythemia VeraPrimary MyelofibrosisEssential ThrombocythemiaChronic Neutrophilic LeukemiaChronic Eosinophilic LeukemiaStages of Chronic...
NCI/PDQ^® Patients: Myelodysplastic Syndromes Treatment (PDQ®) TABLE OF CONTENTS General Information About Myelodysplastic Syndromes Stages of Myelodysplastic SyndromesTreatment Option OverviewTreatment Options for Myelodysplastic SyndromesDe Novo and Secondary Myelodysplastic SyndromesPreviously Treated...
NCI/PDQ^® Patients: Myelodysplastic/Myeloproliferative Diseases TABLE OF CONTENTS DescriptionWhat are myelodysplastic/myeloproliferative diseasesStage ExplanationStages of myelodysplastic/myeloproliferative diseasesTreatment Option OverviewHow myelodysplastic/myeloproliferative diseases are treatedTreatment by...
NCI/PDQ^® Profesionales De Salud: Neoplasias mielodisplásicas o mieloproliferativas: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre las neoplasias mielodisplásicas o mieloproliferativasLeucemia mielomonocítica crónicaDescripción de la enfermedad Descripción del tratamiento para las neoplasias ...
NCI/PDQ^® Profesionales De Salud: Síndromes mielodisplásicos: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre los síndromes mielodisplásicosIncidencia y mortalidadPronósticoPatologíaCaracterísticas clínicasFactores de riesgoSumario relacionadoEnsayos clínicos en...
NCI/PDQ^® Profesionales De Salud: Trastornos mieloproliferativos crónicos: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre los trastornos mieloproliferativos crónicosLeucemia mielógena crónicaPolicitemia veraDescripción de la enfermedadDescripción del tratamientoEnsayos clínicos en...